• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    81 Biggest Movers From Yesterday

    5/5/22 4:31:33 AM ET
    $AIKI
    $AKAM
    $ALNA
    $AMRN
    Specialty Chemicals
    Consumer Discretionary
    Real Estate
    Real Estate
    Get the next $AIKI alert in real time by email

    Gainers

    • Rail Vision Ltd. (NASDAQ:RVSN) shares climbed 62.4% to close at $2.16 on Wednesday after gaining around 5% on Tuesday.
    • TransMedics Group, Inc. (NASDAQ:TMDX) jumped 40.3% to close at $30.69 after better than expected Q1 earnings and 2022 guidance.
    • Aclarion, Inc. (NASDAQ:ACON) jumped 36.6% to settle at $2.35 after declining over 5% on Tuesday. The company had its IPO on April 22.
    • Alaunos Therapeutics, Inc. (NASDAQ:TCRT) jumped 36% to settle at $0.7547 after jumping around 13% on Tuesday.
    • Bright Health Group, Inc. (NYSE:BHG) gained 33.3% to close at $2.24 after the company reported better-than-expected Q1 sales results and reaffirmed FY22 guidance.
    • Super Micro Computer, Inc. (NASDAQ:SMCI) climbed 31.2% to settle at $30.69 after the company reported better-than-expected Q3 EPS and sales results and raised Q4 guidance.
    • Livent Corporation (NYSE:LTHM) gained 30.3% to close at $28.55 after the company reported better-than-expected Q1 results and raised FY22 guidance.
    • AIkido Pharma Inc. (NASDAQ:AIKI) jumped 30.1% to settle at $0.4622. AIkido Pharma reported strategic investment in social communications platform, Discord.
    • BlueLinx Holdings Inc. (NYSE:BXC) gained 28.5% to close at $98.39 after the company reported better-than-expected Q1 EPS and sales results and increased its share buyback to $100 million.
    • Superior Industries International, Inc. (NYSE:SUP) shares jumped 28% to close at $4.11 following better-than-expected Q1 results.
    • CarParts.com, Inc. (NASDAQ:PRTS) shares gained 27.2% to close at $8.65 after the company reported better-than-expected Q1 EPS and sales results.
    • Locafy Limited (NASDAQ:LCFY) rose 26.3% to close at $1.49.
    • eHealth, Inc. (NASDAQ:EHTH) jumped 24.9% to settle at $10.35 after the company reported better-than-expected Q1 sales results.
    • China Liberal Education Holdings Limited (NASDAQ:CLEU) gained 23.5% to close at $2.1850. China Liberal Education won project bid from Fuzhou Melbourne Polytechnic for construction of smart language training experimental classrooms with cloud for $150,000.
    • Kimball International, Inc. (NASDAQ:KBAL) surged 22.8% to close at $9.39 after the company reported better-than-expected Q3 sales results and adjusted EPS results were higher year over year.
    • Sharps Technology, Inc. (NASDAQ:STSS) gained 22.7% to close at $1.57 after climbing around 6% on Tuesday.
    • Forge Global Holdings, Inc. (NYSE:FRGE) rose 22.4% to settle at $34.67.
    • Gogoro Inc. (NASDAQ:GGR) jumped 20.5% to close at $7.17.
    • NexImmune, Inc. (NASDAQ:NEXI) gained 20.5% to settle at $3.23.
    • Vivint Smart Home, Inc. (NYSE:VVNT) rose 19.6% to close at $6.47 after the company reported better-than-expected Q1 sales results and reaffirmed FY22 sales guidance.
    • W&T Offshore, Inc. (NYSE:WTI) gained 19.2% to close at $5.90 after the company reported better-than-expected Q1 EPS and sales results.
    • Tenon Medical, Inc. (NASDAQ:TNON) surged 19.2% to settle at $34.56.
    • Global Industrial Company (NYSE:GIC) jumped 18.8% to close at $36.20 following strong Q1 earnings.
    • Clene Inc. (NASDAQ:CLNN) rose 17.6% to settle at $3.14.
    • Eos Energy Enterprises, Inc. (NASDAQ:EOSE) gained 17.6% to close at $2.54.
    • Summit Midstream Partners, LP (NYSE:SMLP) rose 17.3% to close at $20.66 following Q1 results.
    • Chegg, Inc. (NYSE:CHGG) gained 17.1% to close at $20.39 as the stock rebounded after falling following its Q1 earnings report.
    • Cloopen Group Holding Limited (NYSE:RAAS) surged 16.8% to close at $0.80.
    • Meta Data Limited ADS (NYSE:AIU) jumped 16.7% to close at $1.54.
    • JE Cleantech Holdings Limited (NASDAQ:JCSE) gained 16.7% to settle at $5.80.
    • Powell Industries, Inc. (NASDAQ:POWL) rose 16.3% to close at $23.04 after the company reported better-than-expected Q2 EPS and sales results.
    • Imperial Petroleum Inc. (NASDAQ:IMPP) gained 15.5% to settle at $1.04.
    • U.S. Energy Corp. (NASDAQ:USEG) jumped 15.4% to settle at $4.50. U.S. Energy announced plans to acquire Bolt-On assets for $1 million.
    • Zosano Pharma Corporation (NASDAQ:ZSAN) rose 15.3% to close at $1.96. Zosano Pharma recently announced it has suspended its M207 program and implemented a workforce reduction impacting 40% of remaining employees.
    • Huadi International Group Co., Ltd. (NASDAQ:HUDI) gained 15.2% to close at $26.31.
    • Desktop Metal, Inc. (NYSE:DM) surged 15.1% to close at $4.04.
    • SoundHound AI, Inc. (NASDAQ:SOUN) jumped 15% to settle at $14.51. The company recently completed a SPAC merger deal last week and began trading on Thursday.
    • Nuvve Holding Corp. (NASDAQ:NVVE) surged 15% to close at $9.98.
    • HashiCorp, Inc. (NASDAQ:HCP) rose 14.4% to settle at $54.54.
    • A10 Networks, Inc. (NYSE:ATEN) gained 14.3% to close at $16.78 after the company reported better-than-expected Q1 adjusted EPS and sales results.
    • Paycom Software, Inc. (NYSE:PAYC) jumped 13.8% to settle at $328.20 after the company reported better-than-expected Q1 EPS and sales results and issued FY22 and Q2 sales guidance above analyst estimates.
    • Biora Therapeutics, Inc. (NASDAQ:PROG) rose 13.6% to close at $0.9743.
    • Generac Holdings Inc. (NYSE:GNRC) jumped 11.8% to close at $261.78 after the company reported better-than-expected Q1 EPS and sales results. The company also raised its FY22 sales growth guidance.
    • Brickell Biotech, Inc. (NASDAQ:BBI) gained 11.8% to close at $0.26 after the company announced the sale of sofpironium bromide to Botanix Pharmaceuticals for $9 million in upfront and potential near-term regulatory milestone payments. The company is also eligible to receive additional success-based regulatory and sales milestone payments of up to $168 million.
    • The Scotts Miracle-Gro Company (NYSE:SMG) gained 10% to close at $116.57. Scotts Miracle-Gro announced record second-quarter sales in its U.S. consumer segment driven by continued support from its major retail partners.
    • Starbucks Corporation (NASDAQ:SBUX) gained 9.8% to close at $81.64 as the company reported second-quarter revenue of $7.64 billion, which was up 15% year-over-year. The quarterly revenue was a second-quarter record for the company and came in ahead of a consensus estimate of $7.6 billion.


    Losers

    • Connect Biopharma Holdings Limited (NASDAQ:CNTB) shares tumbled 57.7% to close at $0.8202 after the company announced week 12 top-line results from its Phase 2 CBP-307 trial in patients with moderate-to-severe ulcerative colitis.
    • Kezar Life Sciences, Inc. (NASDAQ:KZR) dipped 43.5% to close at $6.96 after the company reported topline results from the PRESIDIO Phase 2 trial of zetomipzomib (KZR-616) in patients with dermatomyositis (DM) and polymyositis (PM), chronic inflammatory diseases of muscle.
    • Amarin Corporation plc (NASDAQ:AMRN) shares tumbled 43.1% to close at $1.56 on Wednesday after it said it would continue suspending 2022 revenue guidance and Q1 earnings came short of expectations. The company reported Q1 sales of $94.6 million, down 33% Y/Y, missing the consensus of $128.37 million.
    • Blue Water Vaccines, Inc. (NASDAQ:BWV) fell 32.7% to settle at $4.34. Blue Water Vaccines S-1 showed registration for 2.4 million share common stock offering via selling shareholders.
    • Tupperware Brands Corporation (NYSE:TUP) fell 32.2% to settle at $12.15 after the company reported worse-than-expected Q1 results and withdrew its FY22 guidance.
    • Lyft, Inc. (NASDAQ:LYFT) fell 29.9% to close at $21.56 after the company reported Q1 earnings results and issued Q2 sales guidance below analyst estimates.
    • The Andersons, Inc. (NASDAQ:ANDE) dropped 26.8% to close at $38.20 after the company reported Q1 earnings results.
    • Shineco, Inc. (NASDAQ:SISI) fell 24.4% to settle at $1.80.
    • Quad/Graphics, Inc. (NYSE:QUAD) fell 23.5% to close at $4.78 following Q1 results.
    • IAMGOLD Corporation (NYSE:IAG) fell 23.3% to close at $2.14 following Q1 results. The company also named Maryse Bélanger as Interim President and CEO.
    • Clovis Oncology, Inc. (NASDAQ:CLVS) declined 20% to close at $1.68 after the company reported worse-than-expected Q1 EPS and sales results.
    • Ostin Technology Group Co., Ltd. (NASDAQ:OST) fell 20% to close at $3.80 on post-IPO volatility.
    • Cyngn Inc. (NASDAQ:CYN) dipped 19.3% to close at $3.17.
    • Harvard Bioscience, Inc. (NASDAQ:HBIO) fell 18.1% to close at $4.63 after the company reported Q1 earnings results.
    • MacroGenics, Inc. (NASDAQ:MGNX) fell 16.9% to close at $6.44 following Q1 results.
    • Blucora, Inc. (NASDAQ:BCOR) fell 16.6% to close at $17.32 after the company reported worse-than-expected Q1 EPS and sales results and issued FY22 adjusted EPS and sales guidance below estimates.
    • Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) dipped 16.4% to close at $0.1416.
    • T Stamp Inc. (NASDAQ:IDAI) dropped 16% to close at $2.47.
    • Blackboxstocks Inc. (NASDAQ:BLBX) fell 15.7% to close at $2.57. The company announced it has completed its platform Integration with E*TRADE allowing users to trade seamlessly through the Blackbox platform.
    • Arko Corp. (NASDAQ:ARKO) dropped 15.2% to close at $8.12 following Q1 earnings.
    • Revolve Group, Inc. (NYSE:RVLV) fell 14.9% to close at $37.01 after the company reported Q1 earnings results.
    • Infinera Corporation (NASDAQ:INFN) dropped 14.6% to close at $6.74 after the company reported worse-than-expected Q1 adjusted EPS and sales results and issued Q2 sales guidance below analyst estimates.
    • Cardiovascular Systems, Inc. (NASDAQ:CSII) fell 14.3% to close at $17.26 after reporting weak quarterly sales.
    • Conduent Incorporated (NASDAQ:CNDT) fell 14.2% to close at $4.65 following Q1 results.
    • Denny's Corporation (NASDAQ:DENN) dipped 13.8% to close at $11.31 after the company reported worse-than-expected Q1 EPS results.
    • XORTX Therapeutics Inc. (NASDAQ:XRTX) fell 12.6% to close at $1.60. XORTX Therapeutics shares jumped 59% on Tuesday after the company announced that dosing of human subjects has been initiated in the XRX-OXY-101 bridging pharmacokinetics study.
    • Brinker International, Inc. (NYSE:EAT) fell 12.2% to close at $34.65 after the company reported worse-than-expected Q1 EPS and sales results. The company also issued FY22 EPS guidance below analyst estimates.
    • LL Flooring Holdings, Inc. (NYSE:LL) fell 12% to close at $13.11 after the company reported worse-than-expected Q1 EPS and sales results.
    • Kymera Therapeutics, Inc. (NASDAQ:KYMR) dropped 11.4% to close at $22.04. Kymera Therapeutics reported worse-than-expected Q1 EPS and sales results.
    • LSB Industries, Inc. (NYSE:LXU) slipped 10% to close at $20.53 after the company reported worse-than-expected Q1 results.
    • Akamai Technologies, Inc. (NASDAQ:AKAM) fell 9.7% to settle at $102.76 after the company reported worse-than-expected Q1 results.
    • Johnson Controls International plc (NYSE:JCI) fell 8.7% to close at $56.52 after the company cut its FY22 EPS guidance below analyst estimates.
    • Red Rock Resorts, Inc. (NASDAQ:RRR) fell 7.5% to close at $41.57 following weak quarterly sales.
    • Herbalife Nutrition Ltd. (NYSE:HLF) shares fell 6.2% to close at $25.85 after the company reported a decline in Q1 EPS results.
    • Skyworks Solutions, Inc. (NASDAQ:SWKS) fell 5% to close at $113.53 following Q2 results.
    Get the next $AIKI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AIKI
    $AKAM
    $ALNA
    $AMRN

    CompanyDatePrice TargetRatingAnalyst
    Eos Energy Enterprises Inc.
    $EOSE
    2/27/2026$20.00Buy → Neutral
    Guggenheim
    eHealth Inc.
    $EHTH
    2/26/2026$2.00Buy → Hold
    Craig Hallum
    Generac Holdlings Inc.
    $GNRC
    2/12/2026$202.00Buy → Neutral
    Guggenheim
    Generac Holdlings Inc.
    $GNRC
    2/12/2026$220.00 → $255.00Buy
    TD Cowen
    Paycom Software Inc.
    $PAYC
    2/12/2026$175.00 → $137.00Market Perform
    BMO Capital Markets
    Andersons Inc.
    $ANDE
    2/5/2026$75.00Buy
    The Benchmark Company
    Andersons Inc.
    $ANDE
    2/5/2026Buy
    The Benchmark Company
    Skyworks Solutions Inc.
    $SWKS
    2/4/2026$85.00 → $75.00Buy
    Craig Hallum
    More analyst ratings

    $AIKI
    $AKAM
    $ALNA
    $AMRN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    W&T Offshore Announces Timing of Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

    HOUSTON, Feb. 27, 2026 (GLOBE NEWSWIRE) -- W&T Offshore, Inc. (NYSE:WTI) (the "Company") today announced the timing of its fourth quarter and full year 2025 earnings release and conference call. The Company said it will issue its fourth quarter and full year 2025 earnings release on Thursday, March 5, 2026, after the close of trading on the NYSE and host a conference call to discuss financial and operational results on Friday, March 6, 2026, at 9:00 a.m. Central Time (10:00 a.m. Eastern Time). Interested parties may participate by dialing (844) 739-3797. International parties may dial (412) 317-5713. Participants should request to be joined to the "W&T Offshore, Inc. Conference Call." Th

    2/27/26 1:30:00 PM ET
    $WTI
    Oil & Gas Production
    Energy

    TransMedics Provides Additional Information on the Impact of the Release of the Valuation Allowance on Deferred Tax Assets on Previously Reported Fourth Quarter Financial Results

    ANDOVER, Mass., Feb. 27, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (NASDAQ:TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today issued additional information on the impact of the valuation allowance on deferred tax assets reported in the Company's fourth quarter financial results for the year ended December 31, 2025. As previously disclosed, in the fourth quarter of 2025, TransMedics released a $103.3 million U.S. tax valuation allowance, which drove recognition of a

    2/27/26 7:00:00 AM ET
    $TMDX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    MacroGenics to Participate in Upcoming Investor Conferences

    ROCKVILLE, MD, Feb. 26, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ:MGNX), a biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today announced that the Company's management team will participate in the following investor conferences in March: TD Cowen 46th Annual Health Care Conference (Boston, MA). MacroGenics' President and CEO, Eric Risser, will participate in a hybrid presentation and fireside chat on Tuesday, March 3, at 3:10 pm ET. MacroGenics' management will also participate in one-on-one meetings.Leerink Partners 2026 Global Healthcare Conference (Miami, FL). Mr. Risser will participate in a fireside chat on

    2/26/26 5:30:00 PM ET
    $MGNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AIKI
    $AKAM
    $ALNA
    $AMRN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Eos Energy downgraded by Guggenheim with a new price target

    Guggenheim downgraded Eos Energy from Buy to Neutral and set a new price target of $20.00

    2/27/26 8:28:11 AM ET
    $EOSE
    Industrial Machinery/Components
    Miscellaneous

    eHealth downgraded by Craig Hallum with a new price target

    Craig Hallum downgraded eHealth from Buy to Hold and set a new price target of $2.00

    2/26/26 8:34:26 AM ET
    $EHTH
    Specialty Insurers
    Finance

    Generac downgraded by Guggenheim with a new price target

    Guggenheim downgraded Generac from Buy to Neutral and set a new price target of $202.00

    2/12/26 7:22:33 AM ET
    $GNRC
    Metal Fabrications
    Consumer Discretionary

    $AIKI
    $AKAM
    $ALNA
    $AMRN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, CFO & CAO Scheiwer Mark J bought $49,504 worth of shares (693 units at $71.44), increasing direct ownership by 5% to 15,370 units (SEC Form 4)

    4 - SCOTTS MIRACLE-GRO CO (0000825542) (Issuer)

    2/25/26 11:29:13 AM ET
    $SMG
    Agricultural Chemicals
    Industrials

    Chief Executive Officer Agadi Harshavardhan V bought $182,909 worth of shares (117,099 units at $1.56) (SEC Form 4)

    4 - CONDUENT Inc (0001677703) (Issuer)

    2/23/26 5:21:51 PM ET
    $CNDT
    Real Estate

    Chief Executive Officer Agadi Harshavardhan V bought $313,720 worth of shares (220,000 units at $1.43) (SEC Form 4)

    4 - CONDUENT Inc (0001677703) (Issuer)

    2/20/26 11:36:25 AM ET
    $CNDT
    Real Estate

    $AIKI
    $AKAM
    $ALNA
    $AMRN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Officer Llewellyn Lindsay Catherine sold $314,755 worth of shares (23,661 units at $13.30), decreasing direct ownership by 3% to 696,850 units (SEC Form 4)

    4 - Lyft, Inc. (0001759509) (Issuer)

    2/27/26 4:51:21 PM ET
    $LYFT
    Real Estate

    Chief Financial Officer Ragen York A. exercised 24,362 shares at a strike of $40.12 and sold $5,739,828 worth of shares (24,362 units at $235.61), increasing direct ownership by 0.00% to 137,182 units (SEC Form 4)

    4 - GENERAC HOLDINGS INC. (0001474735) (Issuer)

    2/27/26 4:10:11 PM ET
    $GNRC
    Metal Fabrications
    Consumer Discretionary

    President Energy Technology Taffe Norman P sold $470,628 worth of shares (1,973 units at $238.53) and exercised 1,040 shares at a strike of $119.54, decreasing direct ownership by 6% to 14,011 units (SEC Form 4)

    4 - GENERAC HOLDINGS INC. (0001474735) (Issuer)

    2/27/26 4:05:54 PM ET
    $GNRC
    Metal Fabrications
    Consumer Discretionary

    $AIKI
    $AKAM
    $ALNA
    $AMRN
    SEC Filings

    View All

    SEC Form 144 filed by Lyft Inc.

    144 - Lyft, Inc. (0001759509) (Subject)

    2/27/26 5:38:52 PM ET
    $LYFT
    Real Estate

    SEC Form 10-K filed by Global Industrial Company

    10-K - GLOBAL INDUSTRIAL Co (0000945114) (Filer)

    2/27/26 5:22:36 PM ET
    $GIC
    Industrial Machinery/Components
    Industrials

    SEC Form 8-K filed by TransMedics Group Inc.

    8-K - TransMedics Group, Inc. (0001756262) (Filer)

    2/27/26 8:25:03 AM ET
    $TMDX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $AIKI
    $AKAM
    $ALNA
    $AMRN
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for MARGENZA issued to MACROGENICS INC

    Submission status for MACROGENICS INC's drug MARGENZA (SUPPL-5) with active ingredient MARGETUXIMAB-CMKB has changed to 'Approval' on 05/25/2023. Application Category: BLA, Application Number: 761150, Application Classification:

    5/29/23 4:45:45 AM ET
    $MGNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for RUBRACA issued to CLOVIS ONCOLOGY INC

    Submission status for CLOVIS ONCOLOGY INC's drug RUBRACA (SUPPL-13) with active ingredient RUCAPARIB CAMSYLATE has changed to 'Approval' on 12/21/2022. Application Category: NDA, Application Number: 209115, Application Classification: Efficacy

    12/22/22 4:37:40 AM ET
    $CLVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for RUBRACA issued to CLOVIS ONCOLOGY INC

    Submission status for CLOVIS ONCOLOGY INC's drug RUBRACA (SUPPL-11) with active ingredient RUCAPARIB CAMSYLATE has changed to 'Approval' on 06/10/2022. Application Category: NDA, Application Number: 209115, Application Classification: Efficacy

    6/13/22 2:20:18 PM ET
    $CLVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AIKI
    $AKAM
    $ALNA
    $AMRN
    Leadership Updates

    Live Leadership Updates

    View All

    Cyngn Adds Former Lyft Exec, Ran Makavy, to Board

    Mr. Makavy led growth at Lyft and later ran its core platform through the 2019 IPO. He also founded Snaptu, which was acquired by Facebook in 2011.MOUNTAIN VIEW, Calif., Feb. 25, 2026 /PRNewswire/ -- Cyngn (NASDAQ:CYN) today announced the appointment of Ran Makavy to its Board of Directors. He brings senior growth and platform leadership experience from Lyft and Facebook, where he helped scale large technology businesses through high-growth phases. At Lyft, Makavy built the growth team which was responsible for getting more drivers and riders to use Lyft and getting them to use

    2/25/26 7:05:00 AM ET
    $CYN
    EDP Services
    Technology

    Johnson Controls signs agreement to acquire Alloy Enterprises, strengthening data center thermal management leadership

    Transaction aligned with Johnson Controls' strategy to unlock cooling innovation and accelerate the AI-based economyEnhances Johnson Controls' leading capabilities in the rapidly growing data center thermal segmentMILWAUKEE, Feb. 18, 2026 /PRNewswire/ -- Johnson Controls (NYSE:JCI), a global technology leader in energy efficiency, decarbonization, thermal management and mission-critical performance, has signed an agreement to acquire Alloy Enterprises, a Boston-based company specializing in a next-generation thermal management platform for high-performance data centers and other mission critical industrial applications. The move will expand Johnson Controls' leadership and capabilities in th

    2/18/26 4:30:00 PM ET
    $JCI
    Industrial Machinery/Components
    Industrials

    Blackboxstocks Inc. (NASDAQ: BLBX) Merger Target, REalloys to Appoint Bob Foresman to its Board of Directors

    Following the Addition of General Jack Keane, REalloys Further Strengthens Board with Addition of Former Vice Chairman of UBS Investment Bank  Blackboxstocks/REalloys Form S-4 has been declared effective by the SEC, and, pending NASDAQ listing approval, the company expects to close the merger DALLAS, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Blackboxstocks Inc. (NASDAQ:BLBX) ("Blackboxstocks" or the "Company") today announced that its merger target, REalloys Inc. ("REalloys"), has entered into a designate director agreement with Bob Foresman. Mr. Foresman will formally join the REalloys Board of Directors upon the closing of the merger between Blackboxstocks and REalloys. Blackboxstocks' regist

    2/18/26 8:00:00 AM ET
    $BLBX
    EDP Services
    Technology

    $AIKI
    $AKAM
    $ALNA
    $AMRN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Eos Energy Enterprises Inc.

    SC 13D/A - Eos Energy Enterprises, Inc. (0001805077) (Subject)

    12/17/24 2:48:02 PM ET
    $EOSE
    Industrial Machinery/Components
    Miscellaneous

    Amendment: SEC Form SC 13D/A filed by Paycom Software Inc.

    SC 13D/A - Paycom Software, Inc. (0001590955) (Subject)

    12/13/24 7:06:11 PM ET
    $PAYC
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by Lyft Inc.

    SC 13G/A - Lyft, Inc. (0001759509) (Subject)

    12/4/24 2:38:58 PM ET
    $LYFT
    Real Estate

    $AIKI
    $AKAM
    $ALNA
    $AMRN
    Financials

    Live finance-specific insights

    View All

    W&T Offshore Announces Timing of Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

    HOUSTON, Feb. 27, 2026 (GLOBE NEWSWIRE) -- W&T Offshore, Inc. (NYSE:WTI) (the "Company") today announced the timing of its fourth quarter and full year 2025 earnings release and conference call. The Company said it will issue its fourth quarter and full year 2025 earnings release on Thursday, March 5, 2026, after the close of trading on the NYSE and host a conference call to discuss financial and operational results on Friday, March 6, 2026, at 9:00 a.m. Central Time (10:00 a.m. Eastern Time). Interested parties may participate by dialing (844) 739-3797. International parties may dial (412) 317-5713. Participants should request to be joined to the "W&T Offshore, Inc. Conference Call." Th

    2/27/26 1:30:00 PM ET
    $WTI
    Oil & Gas Production
    Energy

    Harvard Bioscience Schedules Fourth Quarter 2025 Earnings Conference Call for March 12, 2026 at 8:00 AM ET

    HOLLISTON, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO) will announce its financial results for the quarter ended December 31, 2025, before the market opens on March 12, 2026, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time.  Participants who would like to join the call and ask a question must register here. Once registered, you will receive the dial-in numbers and a unique PIN number.  Participants who would like to join the audio-only webcast should go to our events and presentations on the investor website here. Financial information presented on the call, including the earnings release and a related slide presentati

    2/26/26 7:30:00 AM ET
    $HBIO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Kymera Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update

    KT-621 (STAT6) BROADEN2 Phase 2b trial in atopic dermatitis (AD) ongoing, with data expected by mid-2027 KT-621 BREADTH Phase 2b trial in asthma ongoing, with data expected in late-2027 Initiated dosing in KT-579 (IRF5) Phase 1 healthy volunteer trial with data expected in 2H26 Dr. Neil Graham, experienced biopharma leader, appointed Chief Development Officer Well-capitalized with $1.6 billion in cash as of December 31, 2025, and runway into 2029 Company to hold video conference call and webcast today at 8:30 a.m. ET WATERTOWN, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ:KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral

    2/26/26 7:00:00 AM ET
    $KYMR
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AIKI
    $AKAM
    $ALNA
    $AMRN
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Trading: Significant Buy at Denny's Corporation on Jun 18

    Several insider transactions have taken place at Denny's Corporation recently, with notable activity on June 18, 2024. Sr. VP, CAO & Corp. Controller Gilmore Jay C purchased $78,118 worth of shares, acquiring 12,000 units at $6.51. This transaction increased Gilmore's direct ownership by 11% to 121,227 units based on SEC Form 4. The purchase by Gilmore stands out as a significant move, demonstrating confidence in the company's future prospects. Insider purchases are generally considered bullish signals, indicating insiders believe the stock is undervalued or that positive developments are on the horizon. Looking at earlier transactions, we see a conversion of options by Miller John C on Ma

    6/18/24 10:06:55 PM ET
    $DENN
    Restaurants
    Consumer Discretionary